Literature DB >> 1260696

Association of renal injury with combined cephalothin-gentamicin therapy among patients severely ill with malignant disease.

J E Plager.   

Abstract

There is a high incidence of primary renal tubule damage among patients with malignant disease who die following recent treatment with combinations of cephalothin and gentamicin. Administration of this combination of antibiotics appears to make the patient appreciably more susceptible to severe renal injury if an additional, often minor, insult to the renal tubules is superimposed. In the present study, significant blood loss or bacterial infection not promptly controlled by the antibiotic combination were two factors that provided this additional insult to many patients; the renal injury in these patients could not be attributed to bleeding or infection alone. The combination of cephalothin plus gentamicin carries the potential of causing renal tubule injury and places the patient severely ill with malignant disease at risk for renal failure from many clinical complications which are commonly associated with their primary illness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260696     DOI: 10.1002/1097-0142(197604)37:4<1937::aid-cncr2820370445>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

2.  Effect of cefamandole nafate on the toxicity of tobramycin.

Authors:  J S Wold; S A Turnipseed; W D Broddle; N V Owen
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

4.  Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.

Authors:  D M Hahn; S C Schimpff; V M Young; C L Fortner; H C Standiford; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

5.  Nephrotoxicity of netilmicin in combination with non-aminoglycoside antibiotics.

Authors:  G L Hagstrom; F C Luft; M N Yum; R S Sloan; D R Maxwell
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.